Aims
To accomplish our objectives, this Cancer Partnership aims to:
- Increase the number of traditional, extramural awards on which MMC and TSU faculty serve as Lead PI’s along with collaborative guidance under senior Vanderbilt faculty
- Increase the number of extramural awards to VICC early-stage investigators that address cancer health disparities
- Increase the number of peer-reviewed, MVTCP publications on which a minority-serving institution investigator is first and/or corresponding author
- Increase the number of MVTCP faculty presenting seminars and strengthen the series to foster collaborations within the Partnerships. Reach the critical mass needed for a thriving program of cancer disparities research by recruiting new cancer investigators in Partnership priority fields, such as big data/bioinformatics, immuno-oncology, and dissemination and implementation-focused research
- Expand MVTCP accrual of minority cancer patients for participation in national oncology clinical trials through the newly established Population Research And Clinical Trials In Cancer Equity (PRACTICE) Shared Resource Core
- Strengthen the physical and intellectual infrastructure for research at MMC and TSU through resource-sharing with VICC
- Implement a robust outreach program that supports MVTCP studies of disparities by facilitating partnerships between community organizations and academic researchers, leading to hypothesis-driven research projects in areas that address the needs of the community
- Increase the number of MMC and TSU trainees engaged in cancer research
- Increase awareness of cancer research opportunities and careers for minority high school, undergraduate, graduate and medical students through the development and implementation of new Pathway to Discovery Program and coursework